Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission.
Hu GH, Cheng YF, Zuo YX, Chang YJ, Suo P, Wu J, Jia YP, Lu AD, Li YC, Wang Y, Jiao SC, Zhang LJ, Zhao XY, Yan CH, Xu LP, Zhang XH, Liu KY, Wang Y, Zhang LP, Huang XJ.
Hu GH, et al. Among authors: jiao sc.
Front Immunol. 2022 Jan 7;12:731435. doi: 10.3389/fimmu.2021.731435. eCollection 2021.
Front Immunol. 2022.
PMID: 35069522
Free PMC article.